- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01941186
A Family Centered Intervention to Promote Optimal Child Development
August 30, 2016 updated by: Children's Hospital of Philadelphia
A Family Centered Intervention to Promote Optimal Child Development at the Interface of the Health System and Community
This is a randomized controlled trial aimed at assessing the effectiveness of a patient decision aid (PDA) and text message reminder in promoting early intervention referral completion when infants and toddlers are identified with a developmental concern in the pediatric medical home.
Subjects will be randomized to one of two study arms- (1) intervention (2) control condition.
Subjects in the intervention arm will watch a video PDA and will receive a text message reminder approximately 7 to 14 business days after enrollment if they agree to the early intervention referral.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 days to 3 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Parent-child dyads in which the child is age 0 to 36 months screening positive for developmental concern and receiving care at a practice within Children's Hospital of Philadelphia Pediatric Research Consortium (PeRC).
- Caregivers able to give permission (informed consent).
Exclusion Criteria:
- Primary language other than English
- Children already enrolled in early intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient Decision Aid
After positive screen for a developmental concern the intervention group will receive the Patient Decision Aid (PDA), as well as, a text message reminder to follow up with Early Intervention.
|
Short informational video on developmental delays and early intervention services aimed at helping parents make an informed decision about whether to pursue early intervention services.
|
|
No Intervention: Routine Care
After screening positive for a potential development delay those in the control arm will receive routine care, in this case, a handout explaining Early Intervention services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in the Number of Participants Who Completed Early Intervention Intake and Evaluation Visits Between Treatment Groups
Time Frame: Up to 1 year after randomization
|
Completed intake and evaluation by the early intervention (EI) agency was assessed by parent report and by chart review.
A member of the study team contacted parents within 6 months of the first study visit to obtain this information.
Additionally, a chart review seeking written feedback information regarding referral disposition from the EI agency was completed.
|
Up to 1 year after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Parental Knowledge and Attitudes From Pre- to Post-Intervention
Time Frame: Up to 7 days
|
Pre and post knowledge and attitudes regarding developmental delay and early intervention (EI) were assessed by asking participants to respond to 14 statements using a 6 point Likert scale that ranged from strongly disagree to strongly agree.
Questions mapped to the video decision aid content viewed by participants.
Participants in the intervention arm completed the questions before and after watching the video and participants in the control arm completed the questions sequentially.
Secondary outcome measures assessed in the survey included Parent Uncertainty About Early Intervention and Parental Predisposition for Early Intervention.
|
Up to 7 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parent Uncertainty About Early Intervention
Time Frame: Up to 7 days
|
Parental uncertainty about whether to enroll their child in Early Intervention will be evaluated using a survey.
|
Up to 7 days
|
|
Parental Predisposition for Early Intervention
Time Frame: Up to 7 days
|
Parental predisposition for early intervention services will be measured using surveys.
|
Up to 7 days
|
|
Feasibility of the Patient Decision Aid
Time Frame: Up to 7 days
|
The feasibility of the patient decision aid (PDA) will be measured by calculating the number of individuals who refuse to participate, time that it takes to complete the PDA, and the number of patients who complete the Early Intervention referral.
|
Up to 7 days
|
|
Acceptability of the Patient Decision Aid for Early Intervention Referral
Time Frame: Up to 7 days
|
The acceptability of using the patient decision aid for early intervention will be assessed by having patients and providers complete surveys on the intervention.
|
Up to 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Alexander Fiks, MD, MSCE, Children's Hospital of Philadelphia
- Principal Investigator: Manuel Jimenez, MD, MS, Children's Hospital of Philadelphia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
September 9, 2013
First Submitted That Met QC Criteria
September 9, 2013
First Posted (Estimate)
September 13, 2013
Study Record Updates
Last Update Posted (Estimate)
October 21, 2016
Last Update Submitted That Met QC Criteria
August 30, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 13-010441
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Developmental Delays
-
Children's Hospital of PhiladelphiaCenters for Disease Control and PreventionCompletedDevelopmental DelaysUnited States
-
Taipei Medical UniversityUnknown
-
JeeHyun SuhNational IT Industry Promotion Agency, Republic of KoreaCompleted
-
Taipei Medical UniversityCompletedDevelopmental DelaysTaiwan
-
Ru-Lan HsiehCompleted
-
Oregon Social Learning CenterNational Institute of Mental Health (NIMH)CompletedDevelopmental Delays | School ReadinessUnited States
-
Taipei Medical UniversityUnknown
-
Northwestern UniversityPatient-Centered Outcomes Research InstituteRecruitingDevelopmental DelaysUnited States
-
Hacettepe UniversityCompletedMusculoskeletal Diseases | Genetic Disease | Metabolic Disease | Delays DevelopmentalTurkey
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingNeurodevelopment | Neurodevelopment Outcome | Neurodevelpmental Delays
Clinical Trials on Patient Decision Aid
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
University of UtahPatient-Centered Outcomes Research Institute; Mayo Clinic; Northwestern University and other collaboratorsCompletedAtrial FibrillationUnited States
-
University of LeedsBaxter Healthcare Corporation; National Health Service, United Kingdom; Foundation... and other collaboratorsCompletedChronic Kidney FailureUnited Kingdom
-
The Netherlands Cancer InstituteUMC Utrecht; Dutch Cancer SocietyCompletedBreast CancerNetherlands
-
Maastricht University Medical CenterCatharina Ziekenhuis EindhovenActive, not recruitingActinic Keratoses | Patient Decision AidNetherlands
-
Laval UniversityChaire en transfert de connaissances, éducation et prévention en santé respiratoire... and other collaboratorsCompleted
-
Taipei Medical University Shuang Ho HospitalRecruiting
-
University of AarhusGødstrup Hospital; Region MidtJylland DenmarkNot yet recruiting
-
Maastricht UniversityNot yet recruitingLung Cancer Stage I | Lung Cancer Stage IINetherlands
-
Vejle HospitalThe Ottawa Hospital Research InstituteCompleted